CORONA Remedies Limited
Abu Dhabi Investment Authority bought 39,130 shares of CORONA Remedies Limited for ₹6.77 Cr at ₹1730.00 apiece in a block deal.
Corona Remedies Limited, founded in 2004 and headquartered in Ahmedabad, is a pharmaceutical company manufacturing and distributing medicines across women's healthcare, cardiology, pain management, and urology. The company operates two manufacturing facilities in Gujarat and Himachal Pradesh, holds EU-GMP and WHO certifications, and maintains market leadership positions in multiple therapeutic segments including rank #5 in women's healthcare and pain management.
Sovereign wealth fund of the Emirate of Abu Dhabi, established in 1976 and one of the world's largest SWFs with around USD 1 trillion in assets. Long-term, multi-decade horizon. Indian equities sit inside its emerging markets allocation and ADIA is a consistent anchor in marquee Indian IPOs and large-block deals.